glp 1 and seizures Glucagon-like peptide (GLP-1) Neuroprotective effects of glucagon-like peptide-1

Current research in Psychosomatic Medicine regarding the Restrained Eating phenomenon highlights that biological restriction, even if unintentional, leads to increased cortisol and a heightened neural sensitivity to food cues

Metabolic impact : The mechanisms by which these medications improve insulin secretion, suppress glucagon, delay gastric emptying, and reduce appetite are all dose-related

Rev Cardiovasc Med 21(4):531540

Hypomagnesemia (low magnesium) may occur with prolonged diarrhea or inadequate intake

If the redness spreads or becomes very warm to the touch, it could indicate a more significant issue

Glucagon-like peptide-1 (GLP-1) agonists represent a class of medications that mimic the action of the naturally occurring incretin hormone GLP-1